Abstract:Keywords: <ul><li><a href="/keyword/Antimicrobial+Peptides">antimicrobial peptides</a></li><li><a href="/keyword/Appropriate+Formulation">appropriate formulation</a></li><li><a href="/keyword/Chemical+Modification">chemical modification</a></li><li><a href="/keyword/De+Novo+Design">de novo design</a></li><li><a href="/keyword/Lipopeptide">lipopeptide</a></li><li><a href="/keyword/Pegylation">PEGylation</a></li><li><a href="/keyword/Peptidomimetic">peptidomimetic</a></li><li><a href="/keyword/Prodrug">prodrug</a></li><li><a href="/keyword/Protease+Stability">protease stability</a></li><li><a href="/keyword/Unnatural+Amino+Acid">unnatural amino acid</a></li></ul><h2>References</h2><ul class="rlist separator"><li class="references__item">1. Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15(11), 689–696 (2017).<a href="/servlet/linkout?suffix=B1&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1038%2Fnrmicro.2017.75">Crossref</a>, <a href="/servlet/linkout?suffix=B1&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=28757648">Medline</a>, <a href="/servlet/linkout?suffix=B1&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2sXht1CktLzN">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sommer+MOA%2C+Munck+C%2C+Toft-Kehler+RV%2C+Andersson+DI.+Prediction+of+antibiotic+resistance%3A+time+for+a+new+preclinical+paradigm%3F+Nat.+Rev.+Microbiol.+15%2811%29%2C+689%E2%80%93696+%282017%29.">Google Scholar</a></li><li class="references__item">2. Mansour SC, Pena OM, Hancock RE. Host defense peptides: front-line immunomodulators. Trends Immunol. 35(9), 443–450 (2014).<a href="/servlet/linkout?suffix=B2&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.it.2014.07.004">Crossref</a>, <a href="/servlet/linkout?suffix=B2&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=25113635">Medline</a>, <a href="/servlet/linkout?suffix=B2&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2cXhtleisb%252FJ">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mansour+SC%2C+Pena+OM%2C+Hancock+RE.+Host+defense+peptides%3A+front-line+immunomodulators.+Trends+Immunol.+35%289%29%2C+443%E2%80%93450+%282014%29.">Google Scholar</a></li><li class="references__item">3. Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 27(4), 323–338 (2019).<a href="/servlet/linkout?suffix=B3&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.tim.2018.12.010">Crossref</a>, <a href="/servlet/linkout?suffix=B3&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30683453">Medline</a>, <a href="/servlet/linkout?suffix=B3&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXivF2hsw%253D%253D">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ghosh+C%2C+Sarkar+P%2C+Issa+R%2C+Haldar+J.+Alternatives+to+conventional+antibiotics+in+the+era+of+antimicrobial+resistance.+Trends+Microbiol.+27%284%29%2C+323%E2%80%93338+%282019%29.">Google Scholar</a></li><li class="references__item">4. Wang J, Dou X, Song J et al. Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med. Res. Rev. 39(3), 831–859 (2019).<a href="/servlet/linkout?suffix=B4&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1002%2Fmed.21542">Crossref</a>, <a href="/servlet/linkout?suffix=B4&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30353555">Medline</a>, <a href="/servlet/linkout?suffix=B4&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXntlGksbY%-Abstract Truncated-

Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides

Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance

Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review

Antimicrobial peptides: Opportunities and challenges in overcoming resistance

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides

Antimicrobial peptides with protease stability: progress and perspective

Antimicrobial Peptides: From Design to Clinical Application

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

Small Molecular Mimetics of Antimicrobial Peptides As a Promising Therapy to Combat Bacterial Resistance.

The evolution of antimicrobial peptide resistance in is severely constrained by random peptide mixtures

Multiple resistance factors collectively promote inoculum-dependent dynamic survival during antimicrobial peptide exposure in Enterobacter cloacae

In situ captured antibacterial action of membrane-incising peptide lamellae

Antimicrobial peptides designed by computational analysis of proteomes

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review

Antimicrobial peptides for combating drug-resistant bacterial infections

Bacterial Pathogens: Potential Source For Antimicrobial Peptides

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance